Open AccessNew drugs for the management of relapsed or refractory diffuse large B-cell lymphoma
Author(s) -
Clémentine Sarkozy,
Laurie H. Sehn
Publication year - 2019
Publication title -
annals of lymphoma
Language(s) - English
Resource type - Journals
ISSN - 2616-2695
DOI - 10.21037/aol.2019.09.01
Subject(s) - medicine , chimeric antigen receptor , oncology , refractory (planetary science) , diffuse large b cell lymphoma , lymphoma , brentuximab vedotin , population , chemotherapy , immunotherapy , cancer , cd30 , physics , environmental health , astrobiology